It is recognized that SCFAs interfere with the cancer cell cycle through DNA epigenetic modifications [137] and histone deacetylase activity (HDAC) inhibition, which is a critical regulator of gene transcription that is often found to be dysregulated in cancer [138]. Here, HDAC9 is linked to cancer.